RGLS Regulus Therapeutics Inc.: institutional ownership and insider trading
1 funds reported holding $135K of Regulus Therapeutics Inc. in their latest 13F filings; in Q3 2025 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of RGLS
- Nuveen Asset Management, LLC — $135K
Recent RGLS insider trades
- Jun 3, 2025: Klassen Preston bought 12,000 shares ($95.9K)
- Jan 30, 2025: Baltimore David bought 19,610 shares ($20.8K)
- Jan 30, 2025: Hagan Joseph P bought 50,000 shares ($54.5K)
- Jan 14, 2025: Hagan Joseph P sold 127,054 shares ($160K)